News & Events

SPR Therapeutics Promotes Dr. Joseph Boggs to SVP of Research and Development

September 7, 2017

SPR Therapeutics Promotes Dr. Joseph Boggs to SVP of Research and Development CLEVELAND, Sept. 07, 2017 (GLOBE NEWSWIRE) — SPR® Therapeutics, LLC (SPR), a private medical device company that has …

Category: News

Patient Factors Affecting Surgeon Selection and the Decision to Delay Total Knee Arthroplasty

August 14, 2017

Delaying total knee arthroplasty (TKA) carries an increased likelihood of poor rehabilitation outcomes. Read the full article (PDF)

Category: News

Opioid Concerns and Work Interference Cited as Top Reasons to Delay Knee Replacement Surgery

August 3, 2017

Opioid Concerns and Work Interference Cited as Top Reasons to Delay Knee Replacement Surgery New survey shows patients often delay surgery for more than two years; 92% of respondents would seek …

Category: News

SPR Therapeutics Awarded $6M Contract from the United States Department of Defense to Advance Non-opioid Pain Relief Therapy

May 15, 2017

SPR Therapeutics Awarded $6M Contract From the United States Department of Defense to Advance Non-Opioid Pain Relief Therapy DoD contract furthers pain management therapy using the SPRINT™ PNS System; …

Category: News

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

SPR Therapeutics Promotes Dr. Joseph Boggs to SVP of Research and Development

Patient Factors Affecting Surgeon Selection and the Decision to Delay Total Knee Arthroplasty

Opioid Concerns and Work Interference Cited as Top Reasons to Delay Knee Replacement Surgery

SPR Therapeutics Awarded $6M Contract from the United States Department of Defense to Advance Non-opioid Pain Relief Therapy

SPR® Therapeutics Debuts New SPRINT® PNS Data for Low Back, Shoulder, Knee, and Headache at the 23rd Annual ASRA Pain Medicine Meeting

Ben Austin, CFO and COO of SPR® Therapeutics, Named to Crain’s Cleveland Business 40 Under 40 List

SPR Therapeutics Founder and CEO Maria Bennett on managing pain with nerve stimulation, not drugs: Women Who Lead

Publication of a Retrospective Chart Review of SPRINT® PNS Treatment for Shoulder Pain